Login to Your Account

Hana Licenses Zensana To Par, Focuses On Oncology Pipeline

By Jim Shrine

Thursday, August 2, 2007
Hana Biosciences Inc., which earlier this year withdrew a new drug application filing for the antiemetic agent Zensana, licensed the product to Par Pharmaceutical Cos. Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription